![B2B Payment Solutions Ltd Secures FCA AEMI Approval to Offer e-Payment Services in UK and Europe - FinTech Futures: Global fintech news & intelligence B2B Payment Solutions Ltd Secures FCA AEMI Approval to Offer e-Payment Services in UK and Europe - FinTech Futures: Global fintech news & intelligence](https://mms.businesswire.com/media/20200909005413/en/819317/5/black_background.jpg)
B2B Payment Solutions Ltd Secures FCA AEMI Approval to Offer e-Payment Services in UK and Europe - FinTech Futures: Global fintech news & intelligence
AM Best Assigns Performance Assessment to Corin Underwriting Limited and Corin Underwriting (Europe) GmbH
![Ultivue on X: "We've expanded presence in Europe! Ultivue EMEA has an experienced scientific and commercial staff located throughout Europe (UK, France, Germany, Italy) to engage and support the European biomedical community. Ultivue on X: "We've expanded presence in Europe! Ultivue EMEA has an experienced scientific and commercial staff located throughout Europe (UK, France, Germany, Italy) to engage and support the European biomedical community.](https://pbs.twimg.com/media/Dz8QZpQXgAEcXKO.png)
Ultivue on X: "We've expanded presence in Europe! Ultivue EMEA has an experienced scientific and commercial staff located throughout Europe (UK, France, Germany, Italy) to engage and support the European biomedical community.
![Evolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U Formulation of Jeuveau® - PharmiWeb.com Evolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U Formulation of Jeuveau® - PharmiWeb.com](https://mms.businesswire.com/media/20231107569049/en/1788236/22/LOGO_NEW_SMALL.jpg)
Evolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U Formulation of Jeuveau® - PharmiWeb.com
![Brainstorm Cell Therapeutics Inc. (BCS) Investor Notice: Robbins LLP Reminds Investors of Class Action Against Brainstorm Cell Therapeutics Inc. - PharmiWeb.com Brainstorm Cell Therapeutics Inc. (BCS) Investor Notice: Robbins LLP Reminds Investors of Class Action Against Brainstorm Cell Therapeutics Inc. - PharmiWeb.com](https://mms.businesswire.com/media/20231106585645/en/805463/22/business_Wire_Robbins_LLP.jpg)
Brainstorm Cell Therapeutics Inc. (BCS) Investor Notice: Robbins LLP Reminds Investors of Class Action Against Brainstorm Cell Therapeutics Inc. - PharmiWeb.com
Otsuka and Astex announce that the European Commission has approved INAQOVI® (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia
![AVer Europe: How Artificial Intelligence Is Enhancing the Business Meeting Experience - UKTN | UK tech news AVer Europe: How Artificial Intelligence Is Enhancing the Business Meeting Experience - UKTN | UK tech news](https://mms.businesswire.com/media/20210622005764/en/886881/5/4387937cAVer_logo.jpg)
AVer Europe: How Artificial Intelligence Is Enhancing the Business Meeting Experience - UKTN | UK tech news
![Altice Europe Confirms That Its Fully Owned Subsidiary Hot Has Submitted an Offer for Partner Communications - DutchNews.nl Altice Europe Confirms That Its Fully Owned Subsidiary Hot Has Submitted an Offer for Partner Communications - DutchNews.nl](https://mms.businesswire.com/media/20200129005294/en/687841/5/altice_logo_pos_pr_rgb.jpg)